Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Added Value of Interactive 3-D Stereo Vision Echocardiography in the Heart Valve Team: A Post Hoc Analysis for Optimal Decision Making in Patients With Mitral Valve Regurgitation.

Pisowodzka IK, Gründeman PF, Meijboom F, van Aarnhem G, Meijer R, Cramer MJ, Teske AJ, van der Spoel T, Wind A, Dieleman S, Suyker W, Chamuleau SAJ.

Innovations (Phila). 2020 Jan 7:1556984519887973. doi: 10.1177/1556984519887973. [Epub ahead of print]

PMID:
31910690
2.

Clinical research study implementation of case-finding strategies for heart failure and chronic obstructive pulmonary disease in the elderly with reduced exercise tolerance or dyspnea: A cluster randomized trial.

van Mourik Y, Rutten FH, Bertens LCM, Cramer MJM, Lammers JJ, Gohar A, Reitsma JB, Moons KGM, Hoes AW.

Am Heart J. 2019 Sep 1;220:73-81. doi: 10.1016/j.ahj.2019.08.021. [Epub ahead of print]

PMID:
31790904
3.

Dissociation between hypertrophy and fibrosis in the left ventricle early after experimental kidney transplantation.

Krebber MM, Papazova DA, Oosterhuis NR, Mokry M, Cramer MJ, Cheng C, Joles JA, Verhaar MC.

J Hypertens. 2019 Oct 24. doi: 10.1097/HJH.0000000000002285. [Epub ahead of print]

PMID:
31652182
4.

Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetes.

de Vries TI, de Valk HW, van der Graaf Y, de Borst GJ, Cramer MJM, Jaap Kappelle L, Visseren FLJ, Westerink J; SMART study group.

Diabetes Res Clin Pract. 2019 Nov;157:107880. doi: 10.1016/j.diabres.2019.107880. Epub 2019 Oct 16.

PMID:
31628967
5.

Evaluation of Disease Progression in Arrhythmogenic Cardiomyopathy: The Change of Echocardiographic Deformation Characteristics Over Time.

Taha K, Mast TP, Cramer MJ, van der Heijden JF, Asselbergs FW, Doevendans PA, Teske AJ.

JACC Cardiovasc Imaging. 2019 Oct 11. pii: S1936-878X(19)30856-3. doi: 10.1016/j.jcmg.2019.08.014. [Epub ahead of print] No abstract available.

PMID:
31607671
6.

Hemodynamic Optimization in Cardiac Resynchronization Therapy: Should We Aim for dP/dtmax or Stroke Work?

Zweerink A, Salden OAE, van Everdingen WM, de Roest GJ, van de Ven PM, Cramer MJ, Doevendans PA, van Rossum AC, Vernooy K, Prinzen FW, Meine M, Allaart CP.

JACC Clin Electrophysiol. 2019 Sep;5(9):1013-1025. doi: 10.1016/j.jacep.2019.05.020. Epub 2019 Jul 31.

PMID:
31537329
7.

Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.

Eisenga MF, Emans ME, van der Putten K, Cramer MJ, Diepenbroek A, Velthuis BK, Doevendans PA, Verhaar MC, Joles JA, Bakker SJL, Nolte IM, Braam B, Gaillard CAJM.

J Am Heart Assoc. 2019 Aug 20;8(16):e011130. doi: 10.1161/JAHA.118.011130. Epub 2019 Aug 17.

8.

Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.

Brandt MM, Nguyen ITN, Krebber MM, van de Wouw J, Mokry M, Cramer MJ, Duncker DJ, Verhaar MC, Joles JA, Cheng C.

J Cell Mol Med. 2019 Oct;23(10):6666-6678. doi: 10.1111/jcmm.14542. Epub 2019 Jul 31.

9.

Comparison of MAGGIC and MECKI risk scores to predict mortality after cardiac rehabilitation among Dutch heart failure patients.

Kouwert IJ, Bakker EA, Cramer MJ, Snoek JA, Eijsvogels TM.

Eur J Prev Cardiol. 2019 Jul 26:2047487319865730. doi: 10.1177/2047487319865730. [Epub ahead of print] No abstract available.

PMID:
31349775
10.

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all-cause mortality: Findings from the SMART cohort.

Sharif S, Groenwold RHH, van der Graaf Y, Berkelmans GFN, Cramer MJ, Visseren FLJ, Westerink J; SMART study group.

Diabetes Obes Metab. 2019 Aug;21(8):1935-1943. doi: 10.1111/dom.13759. Epub 2019 May 23.

11.

Effectiveness of the European Society of Cardiology/Heart Failure Association website 'heartfailurematters.org' and an e-health adjusted care pathway in patients with stable heart failure: results of the 'e-Vita HF' randomized controlled trial.

Wagenaar KP, Broekhuizen BDL, Jaarsma T, Kok I, Mosterd A, Willems FF, Linssen GCM, Agema WRP, Anneveldt S, Lucas CMHB, Mannaerts HFJ, Wajon EMCJ, Dickstein K, Cramer MJ, Landman MAJ, Hoes AW, Rutten FH.

Eur J Heart Fail. 2019 Feb;21(2):238-246. doi: 10.1002/ejhf.1354. Epub 2018 Nov 28.

12.

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model.

Kaasenbrood L, Bhatt DL, Dorresteijn JAN, Wilson PWF, D'Agostino RB Sr, Massaro JM, van der Graaf Y, Cramer MJM, Kappelle LJ, de Borst GJ, Steg PG, Visseren FLJ.

J Am Heart Assoc. 2018 Aug 21;7(16):e009217. doi: 10.1161/JAHA.118.009217.

13.

Atrioventricular optimization in cardiac resynchronization therapy with quadripolar leads: should we optimize every pacing configuration including multi-point pacing?

van Everdingen WM, Zweerink A, Salden OAE, Cramer MJ, Doevendans PA, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M.

Europace. 2019 Jan 1;21(1):e11-e19. doi: 10.1093/europace/euy138.

PMID:
30052906
14.

Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniques.

Zweerink A, van Everdingen WM, Nijveldt R, Salden OAE, Meine M, Maass AH, Vernooy K, de Lange FJ, Vos MA, Croisille P, Clarysse P, Geelhoed B, Rienstra M, van Gelder IC, van Rossum AC, Cramer MJ, Allaart CP.

ESC Heart Fail. 2018 Dec;5(6):1130-1140. doi: 10.1002/ehf2.12335. Epub 2018 Jul 26.

15.

Pressure-Volume Loop Analysis of Multipoint Pacing With a Quadripolar Left Ventricular Lead in Cardiac Resynchronization Therapy.

van Everdingen WM, Zweerink A, Salden OAE, Cramer MJ, Doevendans PA, Engels EB, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M.

JACC Clin Electrophysiol. 2018 Jul;4(7):881-889. doi: 10.1016/j.jacep.2018.02.005. Epub 2018 Mar 28.

16.

A Change of Heart: Yield of Cardiac Imaging in Acute Stroke Workup.

Kauw F, Dankbaar JW, Habets J, Cramer MJM, de Jong HWAM, Velthuis BK, Kappelle LJ.

Case Rep Neurol. 2018 May 30;10(2):118-123. doi: 10.1159/000489254. eCollection 2018 May-Aug.

17.

Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?

van Everdingen WM, Zweerink A, Cramer MJ, Doevendans PA, Nguyên UC, van Rossum AC, Prinzen FW, Vernooy K, Allaart CP, Meine M.

Circ Arrhythm Electrophysiol. 2018 Mar;11(3):e005912. doi: 10.1161/CIRCEP.117.005912.

PMID:
29874169
18.

Regional Left Ventricular Electrical Activation and Peak Contraction Are Closely Related in Candidates for Cardiac Resynchronization Therapy.

Mafi-Rad M, Van't Sant J, Blaauw Y, Doevendans PA, Cramer MJ, Crijns HJ, Prinzen FW, Meine M, Vernooy K.

JACC Clin Electrophysiol. 2017 Aug;3(8):854-862. doi: 10.1016/j.jacep.2017.03.014. Epub 2017 Aug 2.

19.

Chemotherapy-Related Cardiac Dysfunction: A Systematic Review of Genetic Variants Modulating Individual Risk.

Linschoten M, Teske AJ, Cramer MJ, van der Wall E, Asselbergs FW.

Circ Genom Precis Med. 2018 Jan;11(1):e001753. doi: 10.1161/CIRCGEN.117.001753.

PMID:
29557343
20.

The Prognostic Value of Right Ventricular Deformation Imaging in Early Arrhythmogenic Right Ventricular Cardiomyopathy.

Mast TP, Taha K, Cramer MJ, Lumens J, van der Heijden JF, Bouma BJ, van den Berg MP, Asselbergs FW, Doevendans PA, Teske AJ.

JACC Cardiovasc Imaging. 2019 Mar;12(3):446-455. doi: 10.1016/j.jcmg.2018.01.012. Epub 2018 Mar 14.

PMID:
29550307
21.

Reference Values for Physical Stress Echocardiography in Asymptomatic Patients after Mitral Valve Repair.

Jansen R, Urgel K, Cramer MJ, van Aarnhem EEHL, Zwetsloot PPM, Doevendans PA, Kluin J, Chamuleau SAJ.

Front Surg. 2018 Feb 19;5:6. doi: 10.3389/fsurg.2018.00006. eCollection 2018.

22.

Comparison of strain parameters in dyssynchronous heart failure between speckle tracking echocardiography vendor systems.

van Everdingen WM, Maass AH, Vernooy K, Meine M, Allaart CP, De Lange FJ, Teske AJ, Geelhoed B, Rienstra M, Van Gelder IC, Vos MA, Cramer MJ.

Cardiovasc Ultrasound. 2017 Oct 18;15(1):25. doi: 10.1186/s12947-017-0116-5.

23.

Comparison of strain imaging techniques in CRT candidates: CMR tagging, CMR feature tracking and speckle tracking echocardiography.

van Everdingen WM, Zweerink A, Nijveldt R, Salden OAE, Meine M, Maass AH, Vernooy K, De Lange FJ, van Rossum AC, Croisille P, Clarysse P, Geelhoed B, Rienstra M, Van Gelder IC, Vos MA, Allaart CP, Cramer MJ.

Int J Cardiovasc Imaging. 2018 Mar;34(3):443-456. doi: 10.1007/s10554-017-1253-5. Epub 2017 Oct 17.

24.

Combining computer modelling and cardiac imaging to understand right ventricular pump function.

Walmsley J, van Everdingen W, Cramer MJ, Prinzen FW, Delhaas T, Lumens J.

Cardiovasc Res. 2017 Oct 1;113(12):1486-1498. doi: 10.1093/cvr/cvx154. Review.

PMID:
28957534
25.

An easy-to-use scoring index to determine severity of mitral regurgitation by 2D echocardiography in clinical practice.

Jansen R, Hart EA, Peters M, Urgel K, Kluin J, Tietge WJ, Zwart K, Sybrandy KC, Cramer MJM, Chamuleau SAJ.

Echocardiography. 2017 Sep;34(9):1275-1283. doi: 10.1111/echo.13636. Epub 2017 Aug 22.

PMID:
28833463
26.

Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.

Engelen SE, van der Graaf Y, Stam-Slob MC, Grobbee DE, Cramer MJ, Kappelle LJ, de Borst GJ, Visseren FLJ, Westerink J; SMART study group.

Int J Cardiol. 2017 Dec 1;248:301-307. doi: 10.1016/j.ijcard.2017.07.081. Epub 2017 Jul 23.

PMID:
28802735
27.

Echocardiographic Prediction of Cardiac Resynchronization Therapy Response Requires Analysis of Both Mechanical Dyssynchrony and Right Ventricular Function: A Combined Analysis of Patient Data and Computer Simulations.

van Everdingen WM, Walmsley J, Cramer MJ, van Hagen I, De Boeck BWL, Meine M, Delhaas T, Doevendans PA, Prinzen FW, Lumens J, Leenders GE.

J Am Soc Echocardiogr. 2017 Oct;30(10):1012-1020.e2. doi: 10.1016/j.echo.2017.06.004. Epub 2017 Aug 8.

PMID:
28801203
28.

Physical Activity and Characteristics of the Carotid Artery Wall in High-Risk Patients-The SMART (Second Manifestations of Arterial Disease) Study.

Boss HM, van der Graaf Y, Visseren FLJ, Van den Berg-Vos RM, Bots ML, de Borst GJ, Cramer MJ, Kappelle LJ, Geerlings MI; SMART Study Group.

J Am Heart Assoc. 2017 Jul 23;6(7). pii: e005143. doi: 10.1161/JAHA.116.005143.

29.

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis.

Berkelmans GFN, van der Graaf Y, Dorresteijn JAN, de Borst GJ, Cramer MJ, Kappelle LJ, Westerink J, Visseren FLJ; SMART study group.

Int J Cardiol. 2018 Jan 15;251:96-102. doi: 10.1016/j.ijcard.2017.07.026. Epub 2017 Jul 14.

30.

Inter-arm systolic blood pressure differences, relations with future vascular events and mortality in patients with and without manifest vascular disease.

Kranenburg G, Spiering W, de Jong PA, Kappelle LJ, de Borst GJ, Cramer MJ, Visseren FLJ, Aboyans V, Westerink J; SMART study group.

Int J Cardiol. 2017 Oct 1;244:271-276. doi: 10.1016/j.ijcard.2017.06.044. Epub 2017 Jun 13.

PMID:
28641891
31.

Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the MARC study - authors reply.

Maass AH, Vernooy K, Cramer MJ, Vos MA, Rienstra M, Van Gelder IC; MARC investigators.

Europace. 2018 Feb 1;20(2):393. doi: 10.1093/europace/eux169. No abstract available.

PMID:
28582522
32.

Identification of vascular patients at very high risk for recurrent cardiovascular events: validation of the current ACC/AHA very high risk criteria.

van den Berg MJ, Bhatt DL, Kappelle LJ, de Borst GJ, Cramer MJ, van der Graaf Y, Steg PG, Visseren FLJ; SMART study group; REACH Registry investigators.

Eur Heart J. 2017 Nov 14;38(43):3211-3218. doi: 10.1093/eurheartj/ehx102.

PMID:
28369481
33.

Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study.

Maass AH, Vernooy K, Wijers SC, van 't Sant J, Cramer MJ, Meine M, Allaart CP, De Lange FJ, Prinzen FW, Gerritse B, Erdtsieck E, Scheerder COS, Hill MRS, Scholten M, Kloosterman M, Ter Horst IAH, Voors AA, Vos MA, Rienstra M, Van Gelder IC.

Europace. 2018 Feb 1;20(2):e1-e10. doi: 10.1093/europace/euw445.

PMID:
28339818
34.

Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.

Bhonsale A, Te Riele ASJM, Sawant AC, Groeneweg JA, James CA, Murray B, Tichnell C, Mast TP, van der Pols MJ, Cramer MJM, Dooijes D, van der Heijden JF, Tandri H, van Tintelen JP, Judge DP, Hauer RNW, Calkins H.

Heart Rhythm. 2017 Jun;14(6):883-891. doi: 10.1016/j.hrthm.2017.02.013. Epub 2017 Feb 12.

35.

Selecting patients with non-ST-elevation acute coronary syndrome for coronary angiography: a nationwide clinical vignette study in the Netherlands.

Engel J, Poldervaart JM, van der Wulp I, Reitsma JB, de Bruijne MC, Bunge JJ, Cramer MJ, Tietge WJ, Uijlings R, Wagner C.

BMJ Open. 2017 Jan 19;7(1):e011213. doi: 10.1136/bmjopen-2016-011213.

36.

Non-invasive measurement of volume-time curves in patients with mitral regurgitation and in healthy volunteers, using a new operator-independent screening tool.

Konings MK, Jansen R, Bosman LP, Rienks R, Chamuleau SAJ, Rademakers FE, Cramer MJ.

Physiol Meas. 2017 Feb;38(2):241-258. doi: 10.1088/1361-6579/38/2/241. Epub 2017 Jan 18.

PMID:
28099167
37.

Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Mast TP, James CA, Calkins H, Teske AJ, Tichnell C, Murray B, Loh P, Russell SD, Velthuis BK, Judge DP, Dooijes D, Tedford RJ, van der Heijden JF, Tandri H, Hauer RN, Abraham TP, Doevendans PA, Te Riele AS, Cramer MJ.

JAMA Cardiol. 2017 Mar 1;2(3):293-302. doi: 10.1001/jamacardio.2016.5034.

PMID:
28097316
38.

The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease.

van Kruijsdijk RC, van der Graaf Y, Algra A, de Borst GJ, Cramer MJ, Siersema PD, Peeters PH, Visseren FL; SMART study group.

J Am Coll Cardiol. 2016 Dec 13;68(23):2588-2589. doi: 10.1016/j.jacc.2016.09.950. No abstract available.

39.

Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy.

Mast TP, Teske AJ, Walmsley J, van der Heijden JF, van Es R, Prinzen FW, Delhaas T, van Veen TA, Loh P, Doevendans PA, Cramer MJ, Lumens J.

J Am Coll Cardiol. 2016 Nov 15;68(20):2185-2197. doi: 10.1016/j.jacc.2016.08.061.

40.

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population.

Kaasenbrood L, Boekholdt SM, van der Graaf Y, Ray KK, Peters RJ, Kastelein JJ, Amarenco P, LaRosa JC, Cramer MJ, Westerink J, Kappelle LJ, de Borst GJ, Visseren FL.

Circulation. 2016 Nov 8;134(19):1419-1429. Epub 2016 Sep 28.

41.

Double-contrast, single-phase computed tomography angiography for ruling out left atrial appendage thrombus prior to atrial fibrillation ablation.

Teunissen C, Habets J, Velthuis BK, Cramer MJ, Loh P.

Int J Cardiovasc Imaging. 2017 Jan;33(1):121-128. doi: 10.1007/s10554-016-0973-2. Epub 2016 Sep 6.

42.

Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Bourfiss M, Te Riele AS, Mast TP, Cramer MJ, VAN DER Heijden JF, VAN Veen TA, Loh P, Dooijes D, Hauer RN, Velthuis BK.

J Cardiovasc Electrophysiol. 2016 Dec;27(12):1420-1428. doi: 10.1111/jce.13094. Epub 2016 Oct 6.

PMID:
27572111
43.

Cardiovascular surveillance in breast cancer treatment: A more individualized approach is needed.

Maas AH, Ottevanger N, Atsma F, Cramer MJ, Leiner T, Poortmans P.

Maturitas. 2016 Jul;89:58-62. doi: 10.1016/j.maturitas.2016.04.015. Epub 2016 Apr 23. Review.

PMID:
27180161
44.

Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.

van Giessen A, Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Liem AH, Hoes AW, Koffijberg H.

Cardiovasc Diabetol. 2016 Mar 22;15:48. doi: 10.1186/s12933-016-0363-z.

45.

Health status of older patients with type 2 diabetes and screen-detected heart failure is significantly lower than those without.

Boonman-de Winter LJ, van Stel HF, Hoes AW, Landman MJ, Liem AH, Rutten GE, Cramer MJ, Rutten FH.

Int J Cardiol. 2016 May 15;211:79-83. doi: 10.1016/j.ijcard.2016.02.147. Epub 2016 Mar 2. No abstract available.

PMID:
26977584
46.

Prolonged Electromechanical Interval Unmasks Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Subclinical Stage.

Mast TP, Teske AJ, Te Riele AS, Groeneweg JA, Van Der Heijden JF, Velthuis BK, Loh P, Doevendans PA, Van Veen TA, Dooijes D, De Bakker JM, Hauer RN, Cramer MJ.

J Cardiovasc Electrophysiol. 2016 Mar;27(3):303-14. doi: 10.1111/jce.12882. Epub 2016 Jan 14.

PMID:
26585103
47.

The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk.

Weijmans M, van der Graaf Y, de Borst GJ, Asselbergs FW, Cramer MJ, Algra A, Visseren FL; SMART study group.

Am Heart J. 2015 Oct;170(4):744-752.e2. doi: 10.1016/j.ahj.2015.06.023. Epub 2015 Jul 3.

PMID:
26386798
48.

Relationship Between Reverse Remodeling and Cardiopulmonary Exercise Capacity in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy.

Mastenbroek MH, Van't Sant J, Versteeg H, Cramer MJ, Doevendans PA, Pedersen SS, Meine M.

J Card Fail. 2016 May;22(5):385-94. doi: 10.1016/j.cardfail.2015.08.342. Epub 2015 Sep 10.

PMID:
26363091
49.

Women Undergoing Coronary Angiography for Myocardial Infarction or Who Present With Multivessel Disease Have a Poorer Prognosis Than Men.

Gijsberts CM, Santema BT, Asselbergs FW, de Kleijn DP, Voskuil M, Agostoni P, Cramer MJ, Vaartjes I, Hoefer IE, Pasterkamp G, den Ruijter HM.

Angiology. 2016 Jul;67(6):571-81. doi: 10.1177/0003319715604762. Epub 2015 Sep 7.

PMID:
26351289
50.

Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort study.

Franssens BT, van der Graaf Y, Kappelle LJ, Westerink J, de Borst GJ, Cramer MJ, Visseren FL; SMART Study Group.

Diabetes Care. 2015 Oct;38(10):1945-51. doi: 10.2337/dc15-0684. Epub 2015 Aug 25.

PMID:
26307608

Supplemental Content

Loading ...
Support Center